Skip to content
Screener

Amgen AMGN Interest Expense

Interest Expense at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$11M+206%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$1.43M-22.7%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$39.9M+25.7%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$5.8M-41.2%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.21M
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$23.78M+2,643%

Segments

By segment

See full
Reportable Segment$673M-3.0%

Other financials

Income statement

See full
Revenue$10.1B+9.5%
Gross profit$7.2B+17.4%
Operating income$3.5B+32.3%
Net income$2.4B+65.9%
EPS (diluted)$4.37+64.9%

Balance sheet

See full
Cash & equivalents$574.0M+5.9%
Total debt$57.3B+2.0%
Total equity$11.7B+57.4%
Total assets$95.6B+8.8%

Cash flow

See full
Operating cash flow$4.0B+75.5%
CapEx$513.0M+39.0%
Free cash flow$3.5B+82.6%

Valuation

See full
Market cap$220.64B+44.0%
Enterprise value$277.37B+32.8%
P/E25.2×+2.1×
P/S5.8×+1.4×

Profitability

See full
Gross margin69.5%+5.0pp
Operating margin30%+6.5pp
Net margin23%+4.0pp
FCF margin26.7%-3.7pp

Returns & leverage

See full
Return on equity91.5%-7.7pp
Debt / equity4.9×-2.7×
Current ratio1.4×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseDebt.

The source filing: Amgen’s 10-Q, filed August 5, 2026.

Filed
Aug 4, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000318154-26-000126
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Total operating expenses6,5406,52312,49213,494
Operating income3,5142,6566,1803,834
Other income (expense):
Interest expense, net(673)(694)(1,330)(1,417)
Other (expense) income, net(73)(394)21,124
Income before income taxes2,7681,5684,8523,541
Provision for income taxes393136658379
Net income$2,375$1,432$4,194$3,162

Item 1. FINANCIAL STATEMENTS

FAQ

What is Amgen's interest expense?
Amgen (AMGN) reported interest expense of $673M in Q2 2026.
How has Amgen's interest expense changed year-over-year?
Amgen's interest expense decreased by 3.0% year-over-year, from $694M to $673M.
What is the long-term trend for Amgen's interest expense?
Over 4 years (2021 to 2025), Amgen's interest expense has grown at a 23.2% compound annual growth rate (CAGR), from $1.2B to $2.76B.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Ask your AI about Amgen's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude